Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syan Biosciences was a private Maryland diagnostics biotechnology company founded in 2006 by Loleta Robinson and Colleen Nye. The company focused on developing a lab-on-a-chip, biomarker-based in vitro diagnostic platform intended for point-of-care testing, with applications in diseases including melanoma, cancer, and heart disease. Publicly available descriptions indicate the company worked on protein chip prototype development in collaboration with University of Maryland-associated researchers and aimed to commercialize handheld diagnostic products while also licensing the technology to biotech and pharmaceutical companies. Later descriptions of the company emphasize novel biomarkers for early melanoma detection. Maryland corporate records indicate the entity is forfeited and not in good standing, suggesting it is no longer active as an operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syan Biosciences.